Danish chemical industry news

• 

  10 March 2026

  RWE Sells Polish Offshore Wind Project to PGE

  PGE acquires 350 MW F.E.W. Baltic II project and Environmental Decision for site 44.E.1. RWE continues to support Poland's energy transition with onshore wind and solar projects.
• 

  10 March 2026

  ORLEN Confirms Gas Discovery in North Sea's Sleipner Area

  Gas and condensate found in Frida Kahlo prospect, estimated at 7.2 million barrels. Production to start by 2026 using existing infrastructure, reducing costs and time.
• 

  9 March 2026

  Novo Nordisk Partners with Hims & Hers to Expand Access to Semaglutide in the US

  Hims & Hers will offer FDA-approved semaglutide medicines at self-pay prices, shifting focus from compounded GLP-1 offerings to increase patient access.
• 

  4 March 2026

  Topsoe Appoints Elena Scaltritti as CEO

  Roeland Baan steps down early as CEO, with Elena Scaltritti taking over on March 5, 2026, following a smooth transition and strong strategic alignment.
• 

  4 March 2026

  Topsoe's 2025 Financial Results Meet Expectations in Tough Market

  Revenue reached DKK 8,197 million. EBIT margin at 8.9%. SAF projects in China. New CEO from March 2026. 2026 outlook: revenue DKK 7,600-8,400 million, EBIT margin 0.0-5.0%.
• 

  2 March 2026

  Novo Nordisk Employee Board Elections Completed

  Four employee representatives and four substitutes were elected to Novo Nordisk's Board. New members join post-AGM on 26 March 2026. Two current members will resign.

• 

  25 February 2026

  Novo Nordisk and Vivtex Collaborate on Oral Medicines for Obesity and Diabetes

  The partnership aims to develop oral biologics for obesity and diabetes, leveraging Vivtex's technology for better bioavailability and Novo Nordisk's expertise in global development and commercialization.
• 

  25 February 2026

  Worley Wins EPCM Contract for Danish Hydrogen Pipeline

  Worley to provide EPCM services for Denmark's hydrogen pipeline, linking green hydrogen production with Germany, enhancing energy security and supporting the green transition.
• 

  24 February 2026

  Genmab Share Capital Increase from Employee Warrant Exercise

  12,313 new shares issued, raising DKK 17.1 million. New shares have no special rights and will be listed on Nasdaq Copenhagen. Total share capital now 64,250,721 shares.
• 

  24 February 2026

  Novo Nordisk's UBT251 Achieves 19.7% Weight Loss in Phase 2 China Trial

  UBT251, a triple agonist, showed significant weight loss and improved health markers in a Chinese phase 2 trial, with a safe and well-tolerated profile.
• 

  23 February 2026

  Novo Nordisk: CagriSema Shows 23% Weight Loss in Trial, Misses Primary Endpoint

  CagriSema achieved 23% weight loss in 84 weeks but didn't match tirzepatide. Further trials will explore higher doses. Safe profile with mild gastrointestinal effects.
• 

  12 February 2026

  thyssenkrupp Q1 2025/2026: Sales Down, EBIT Up, Forecast Confirmed

  Order intake fell due to prior major contracts. Sales dropped 8%, but EBIT rose 10% via APEX program. Transformation progresses with strategic moves in various segments.
• 

  9 February 2026

  Novo Nordisk Sues Hims & Hers Over Unapproved Semaglutide Products

  Novo Nordisk seeks to stop Hims from selling unapproved semaglutide, citing patient safety risks and patent infringement.
• 

  6 February 2026

  Neste Names Jukka Siukosaari as SVP of Public Affairs and Geopolitics

  Jukka Siukosaari, former Finnish ambassador, joins Neste's leadership team to focus on public affairs and geopolitics, leveraging his diplomatic experience for the energy transition.
• 

  5 February 2026

  SPIE Advances ALK's Low-Carbon Transition at Vandeuil Plant

  SPIE replaced gas boilers with heat pumps at ALK's Vandeuil site, cutting CO2 emissions by 305 tons annually and enhancing energy efficiency.
• 

  4 February 2026

  Kemira Enters Finland's Top 5 in Nordic Diversity Index

  Kemira improved its diversity ranking, focusing on gender, age, nationality, and education. The 2026 report highlights AI's role in digital leadership.
• 

  4 February 2026

  Worley Backs AquaDuctus Hydrogen Pipeline in North Sea

  AquaDuctus, a key project in Europe's hydrogen infrastructure, will connect offshore production to the mainland, supporting cross-border collaboration and green hydrogen deployment.
• 

  2 February 2026

  Court Allows Ørsted's Sunrise Wind Project to Resume Construction

  A U.S. court lifted a suspension, allowing the Sunrise Wind Project to restart construction, prioritizing safety and aiming to provide reliable power to New York.
• 

  2 February 2026

  Ørsted Announces New Employee-Elected Board Member

  Leticia Mandiola steps down from Ørsted's board. Arul Gynasegaran, Senior Project Lead, replaces her as the new employee-elected board member.
• 

  31 January 2026

  Novo Nordisk Board Change Announcement

  Thomas Rantzau leaves the Board after 22 years. Tanja Villumsen steps in as the new employee representative.
• 

  27 January 2026

  Statkraft Appoints Tor Lønnum as CFO

  Tor Lønnum, with extensive leadership experience, will start as CFO on 1 Feb 2026, succeeding Tone Aastveit Skuterud. He aims to support Statkraft's strategy and renewable energy goals.
• 

  26 January 2026

  Future North Sea Energy System by European Network Operators

  Europe's energy shift needs offshore wind and hydrogen integration in the North Sea for decarbonization, affordability, and supply security, requiring clear policies and infrastructure.
• 

  26 January 2026

  Danish Energy Agency Approves RWE's Thor Offshore Wind Farm

  Thor offshore wind farm receives a 30-year production license. Construction is on track, with turbine installation starting this spring. Completion expected in 2027 to power 1M Danish homes.
• 

  23 January 2026

  Topsoe to Provide Technology for China's Sustainable Aviation Fuel Project

  The project will use Hydroflex® technology to produce sustainable aviation fuel, aiming to cut CO2 emissions by 700,000 metric tons annually, with operations starting in 2028.
• 

  20 January 2026

  Aspect Biosystems and Novo Nordisk Advance Partnership for Diabetes Medicines

  The partnership focuses on developing cellular therapies for diabetes, integrating technologies, and expanding manufacturing and R&D capabilities across Canada, the US, and Denmark.
• 

  15 January 2026

  Topsoe Names Yassir Ghiyati as CCO

  Yassir Ghiyati, with over 20 years at Topsoe, becomes CCO, succeeding Elena Scaltritti, who will be CEO. He'll oversee global commercial offerings and innovative technologies.
• 

  15 January 2026

  Topsoe Names Yassir Ghiyati as CCO

  Yassir Ghiyati becomes CCO, succeeding Elena Scaltritti, who will be CEO. Ghiyati has 20+ years in engineering, sales, and leadership, previously VP and MD for EMEA.
• 

  7 January 2026

  Genmab and Anthropic Collaborate on AI-Driven R&D Enhancement

  The partnership aims to streamline R&D with AI, enhancing data processing and document generation to boost efficiency and focus on strategic tasks.
• 

  7 January 2026

  Grupa Azoty Secures Multi-Year Fertiliser Deal in Scandinavia

  The contract enhances export strategy, ensuring stable fertiliser supply to Scandinavia, meeting high standards and boosting sales in a key market.
• 

  7 January 2026

  Sunrise Wind Challenges Lease Suspension in Court

  Sunrise Wind seeks a preliminary injunction against a lease suspension, citing legal violations and project delays, impacting energy supply and jobs.